Jamjoom Pharmaceuticals Factory Co.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SA15QGU1UNH6
SAR
156.20
0.7 (0.45%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,500.63
1,318.48
1,100.82
916.67
735.68
805.31
731.73
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,500.63
1,318.48
1,100.82
916.67
735.68
805.31
731.73
Raw Material Cost
570.90
505.97
404.81
329.93
267.94
331.06
312.30
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
335.11
296.32
254.02
233.08
197.84
183.58
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.00
0.67
0.63
0.86
3.18
0.00
0.00
Selling and Distribution Expenses
433.17
394.92
348.47
324.71
248.98
234.34
244.89
Other Expenses
-29.99
-26.53
-22.36
-20.37
-16.66
-18.36
0.00
Total Expenditure (Excl Depreciation)
1,040.23
932.55
784.34
684.85
551.38
565.40
557.19
Operating Profit (PBDIT) excl Other Income
460.4
385.90000000000003
316.5
231.8
184.3
239.89999999999998
174.5
Other Income
20.31
-5.44
1.40
-43.09
8.06
2.82
1.13
Operating Profit (PBDIT)
524.44
412.51
344.50
213.46
216.72
285.23
218.22
Interest
1.00
0.67
0.63
0.86
3.18
0.00
0.00
Exceptional Items
-0.10
-10.34
-5.85
-1.24
-1.04
-10.42
0.00
Gross Profit (PBDT)
929.73
812.51
696.01
586.74
467.74
474.25
419.43
Depreciation
44.08
37.42
26.63
24.73
24.35
42.49
42.55
Profit Before Tax
479.26
364.08
311.39
186.63
188.14
232.31
175.67
Tax
29.30
26.13
23.40
15.00
17.39
24.88
18.74
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
463.80
356.52
292.40
171.31
170.70
206.86
156.93
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
463.80
356.52
292.40
171.31
170.70
206.86
156.93
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
463.80
356.52
292.40
171.31
170.70
206.86
156.93
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
1,716.77
1,490.61
1,404.33
1,216.26
1,231.64
1,179.07
1,069.52
Earnings per share (EPS)
6.63
5.09
4.18
2.45
2.44
2.96
2.24
Diluted Earnings per share
6.63
5.09
4.18
2.45
2.44
2.96
2.24
Operating Profit Margin (Excl OI)
30.66%
28.86%
28.75%
25.29%
25.05%
29.79%
23.85%
Gross Profit Margin
34.87%
30.45%
30.71%
23.06%
28.88%
34.12%
29.82%
PAT Margin
30.91%
27.04%
26.56%
18.69%
23.2%
25.69%
21.45%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 13.81% vs 19.78% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 30.10% vs 21.92% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 20.60% vs 21.83% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 42.86% vs 16.67% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Jamjoom Pharmaceuticals Factory Co. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(SAR)
Change(%)
Net Sales
1,500.63
0
1,500.63
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,500.63
0
1,500.63
Raw Material Cost
570.90
0
570.90
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
335.11
0
335.11
Power Cost
0
0
0.00
Manufacturing Expenses
1.00
0
1.00
Selling and Distribution Expenses
433.17
0
433.17
Other Expenses
-29.99
0.00
-29.99
Total Expenditure (Excl Depreciation)
1,040.23
0
1,040.23
Operating Profit (PBDIT) excl Other Income
460.40
0.00
460.40
Other Income
20.31
0
20.31
Operating Profit (PBDIT)
524.44
0
524.44
Interest
1.00
0
1.00
Exceptional Items
-0.10
0
-0.10
Gross Profit (PBDT)
929.73
0
929.73
Depreciation
44.08
0
44.08
Profit Before Tax
479.26
0
479.26
Tax
29.30
0
29.30
Provisions and contingencies
0
0
0.00
Profit After Tax
463.80
0
463.80
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
463.80
0
463.80
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
463.80
0
463.80
Equity Capital
0
0
0.00
Face Value
10.00
0
0.00
Reserves
1,716.77
0
1,716.77
Earnings per share (EPS)
6.63
0
6.63
Diluted Earnings per share
6.63
0
6.63
Operating Profit Margin (Excl OI)
30.66%
0%
0.00
30.66%
Gross Profit Margin
34.87%
0%
0.00
34.87%
PAT Margin
30.91%
0%
0.00
30.91%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 150.06 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 13.81% vs 19.78% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 46.38 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 30.10% vs 21.92% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 50.41 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 20.60% vs 21.83% in Dec 2024

Annual - Interest
Interest 0.10 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 42.86% vs 16.67% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.66%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024